Ruti Aga Gets Six-Year Ban Over Forged Prescription: Two Years for the Substance, Four for the Tampering

The Athletics Integrity Unit (AIU) has banned Ethiopian marathon runner Ruti Aga for six years, and the case is unusual not because of the substance at its centre but because of the paper used to hide it. In a statement issued on Thursday, the AIU said the 32-year-old had received two years for the presence of a prohibited substance and four years for tampering after she submitted a forged prescription during the investigation. The two periods add up to six years, backdated to 10 September — the date her provisional suspension began. The case traces back to a half marathon in China in March, which Aga won. An in-competition sample collected at that race returned an adverse finding for methylprednisolone. Notably, no performance data appears anywhere in the case file — no finishing time, no splits, no field strength. This is a story about process and integrity, not about running. What the substance is, and what it is not Several media reports have described methylprednisolone as a prohibited steroid. That is technically wrong. It is a glucocorticoid, falling under class S9 of the WADA Prohibited List — not an anabolic steroid, which sits in class S1. The distinction is not semantic; it changes the entire legal shape of the case. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only when administered by injection, orally or rectally. A therapeutic knee injection given out of competition is not, by itself, a violation. It becomes one only if residues are still present in a sample taken in-competition. The decisive question in this case was therefore never steroid use; it was route and timing. The knee injury and the forged paperwork Aga's defence was that she took the medication to treat a knee injury. That is genuinely plausible in sports medicine — intra-articular or peri-articular glucocorticoid injections for knee synovitis are routine among distance runners. The problem was not the medicine. The problem was the evidence. The prescription produced during the investigation was issued by a family member who held no medical registration. The clinic named on the document did not exist. And when questioned, the individual claimed to have used an old prescription pad from a former workplace — a claim the clinic in question explicitly disowned. Three independent verification failures: no doctor, no clinic, no pad. That is where the case turns. With genuine medical records and a credible timeline, Aga had a legitimate defence available. By fabricating the prescription, she closed off the only route that could have worked. The arithmetic of the sanction The structure is standard. Two years for presence, consistent with a Specified Substance finding where intent is not proven; four years for tampering, the Code's default sanction; six years in total. The arithmetic tells us the panel rejected the no-significant-fault mitigation that would have reduced the presence sanction. It also tells us that although forged documentation is itself circumstantial evidence of concealment, it did not aggravate the presence charge. Backdating to 10 September looks like a procedural concession but is not: provisional suspension time simply counts against the ban, so the athlete gains nothing in real terms. The career ledger Aga was, for a period, genuinely elite. She won the 2026 Tokyo Marathon and finished second at three World Marathon Majors. Her personal best is cited at around 2:18:34, set in Berlin in 2026 while finishing second; she ran about 2:20:40 in Tokyo in 2026. Those figures are not independently verified in this report, but her level sits in the 2:18–2:20 bracket. At 32, a six-year ban means a return at roughly 38. Ethiopia's women's marathon depth is so extreme that athletes running under 2:16 struggle for national selection; a 38-year-old returning with a doping record is, for practical purposes, unselectable. The ban is six years on paper. In effect, it is career-ending. The result and prize money from the March race are not addressed in the statement, but under standard AIU practice the competition at which the sample was collected is automatically disqualified. Her results before that date — including the Tokyo title — are not automatically annulled absent evidence of earlier use. The real root cause Treating this as one athlete's ethical lapse misses the point. It is a structural problem of the East African road-racing ecosystem. Knee injuries are common in high-volume marathoners and signal load-bearing failure. Injured runners face strong pressure to keep racing because appearance fees are a large share of income. Glucocorticoids are the cheapest, most available tool for masking that pain. And without a credentialed team physician, treatment runs through informal networks — from which a forged prescription is a short step. A properly managed athlete would have either applied for a TUE or observed the route-specific washout period. Neither appears to have happened. Note too that the four-year tampering sanction came out of an interview, not a document alone; language and translation conditions in AIU interviews are a recurring point of contention. Where testing is heading The race in question was a Chinese half marathon — the kind of fixture that functions as a lucrative, low-risk income tier for East African marathoners between Majors. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. And it raises a fair question: is six years proportionate for a substance with no proven endurance benefit? It will be cited both as evidence of AIU rigour and as evidence of uneven enforcement against African road runners. The truth is that the bulk of the sanction is for the forgery, not the drug — which makes this a document-verification case wearing an anti-doping label. Appeal and counterfactual Aga can appeal to CAS, typically within about 21 days of the reasoned decision, but the odds are poor: the tampering finding rests on documents, and three independent verifications failed. An appeal is more likely to contest duration than outcome. Had she held proper medical records and demonstrated a route and timing defence, the presence charge could have landed at the no-fault or no-significant-fault end — and no tampering charge would have arisen at all. With a correct TUE and correct washout timing, there would have been no case whatsoever. The wider competitive picture is unchanged. Ethiopia's medal capacity does not move because a 32-year-old with no global championship medals leaves the sport. What moves is the integrity landscape: the enforcement frontier has shifted from detection to document verification, and more cases of this profile are likely in the pipeline, because the same informal medical networks serve many athletes in the same training clusters. (Note: this report is based on the AIU's public statement and available public information. Some performance figures have not been independently verified.)